Tim-3 adaptor protein Bat3 is a molecular checkpoint of T cell terminal differentiation and exhaustion
Open accessThe DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
Tim-3 adaptor protein Bat3 regulates T cell terminal differentiation and exhaustion in an mTORC2-dependent manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Tim-3 signaling partially contributes to Bat3-mediated T cell exhaustion. (A) CD4 T cells from Bat3cko × 2D2 and WT 2D2 mice were in vitro differentiated into TH1 cells, and 4 × 106 cells were transferred into C57BL/6 recipient mice to induce EAE. Disease progression was monitored on daily basis until the end of the experiment. Mean disease scores are shown as indicated. (B to E) Ex vivo analyses on transferred 2D2 cells (Va3.2+Vb11+) in the central nervous system (CNS), spleen (SPN), and lymph node (LN) on day 12 (D12) and day 21 (D21) were performed to determine the phenotype of Bat3-deficient CD4 T cells during EAE induction. Error bars indicate mean SEM [*P = 0.01, **P = 0.0085, and ***P = 0.006, unpaired two-tailed t test; ****P = 0.0001, two-way analysis of variance (ANOVA)]. NS, not significant. (F) Naïve CD4 T cells were isolated from Bat3fl/fl, Tim-3cko, Bat3cko × 2D2, and Tim-3×Bat3dko × 2D2 mice and were in vitro differentiated into TH1 cells; 4 × 106 cells were transferred into C57BL/6 recipient mice to induce EAE. Disease progression was monitored on daily basis till the end of experiment. Mean disease scores were shown as indicated. Statistical significance between Tim-3cko × 2D2 and Tim-3×Bat3dko × 2D2 was reached on D12 (**), increasing in significance until cessation of experiment. Statistical significance between Bat3cko × 2D2 and Tim-3 × Bat3dko × 2D2 mice was reached on D8 (*), increasing in significance until cessation of experiment. (G) Ex vivo analyses on transferred 2D2 cells (Va3.2+Vb11+) in the CNS on D21 was performed to determine the phenotype of Bat3fl/fl, Tim-3cko, Bat3cko × 2D2, and Tim-3 × Bat3dko–deficient CD4 T cells during EAE induction. Data represent three independent experiments. Error bars indicate mean SEM (*P = 0.01 and ***P = 0.0012, unpaired two-tailed t test; ****P = 0.0001, two-way ANOVA).](https://figures.cochat.ai/paper-figures/e26f9bf32d03420582098495f3b7ba04/tim-3-adaptor-protein-bat3-is-a-molecular-checkpoint-of-t-cell-terminal-figure-1.jpg)







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Release of BAT3 suggests that FYN tyrosine‐protein kinase links with the TIM‐3 cytoplasmic tail to generate inhibitory signaling that causes anergy of T cells by activating the transmembrane protein phosphoprotein membrane anchor with glycosphingolipid microdomains 1 (PAG1). This prompts the recruitment of tyrosine kinase (CSK), leading to phosphorylating LCK and suppressing T cells [308, 312].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [312]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665 · cited 1×
“As the interaction with Rictor is required for mTOR kinase activity, the regulation of Rictor binding to mTOR would be an important mechanism to control mTORC2 activity (22, 23).”
BackgroundProlonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072
Self-citationDefining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,472
Self-citationMolecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,354
Li, H., van der Leun, A. M., Yofe, I., Lubling, Y., Gelbard-Solodkin, D., van Akkooi, A. C. J., van den Braber, M., Rozeman, E. A., Haanen, J. B. A. G., Blank, C. U., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.043 · Cited by 1,101
Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
Jin, H.-T., Anderson, A. C., Tan, W. G., West, E. E., Ha, S.-J., Araki, K., Freeman, G. J., Kuchroo, V. K., & Ahmed, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009731107 · Cited by 858
Self-citationImmunoregulatory functions of mTOR inhibition
Thomson, A. W., Turnquist, H. R., & Raimondi, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2546 · Cited by 847 · cited 3×
“The molecular mechanism by which mTORC1 is regulated has been extensively investigated, but knowledge of mTORC2 regulation is still limited (40).”
BackgroundInfluential
Cited by
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
Endoplasmic reticulum stress—a key guardian in cancer
Zhang, W., Shi, Y., Oyang, L., Cui, S., Li, S., Li, J., Liu, L., Li, Y., Peng, M., Tan, S., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02110-3 · Cited by 173
“A study had elucidated a potential mechanism by which DCs de fi cient in the adapter protein BAT3, which interacts with TIM-3 on T cells, exhibit a hyperactive UPR, leading to the development of a tolerogenic phenotype that subsequently attenuates the ef fi cacy of anti-tumor T cell responses [145].”
BackgroundDecoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity
Salvagno, C., Mandula, J. K., Rodríguez, P. C., & Cubillos‐Ruiz, J. R. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.06.006 · Cited by 144
Control of immune cell function by the unfolded protein response
Conza, G. D., Ho, P., Cubillos‐Ruiz, J. R., & Huang, S. C. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00838-0 · Cited by 117
İmani, S., Farghadani, R., Roozitalab, G., Maghsoudloo, M., Emadi, M., Moradi, A., Abedi, B., & Kaboli, P. J. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03394-8 · Cited by 132
Beyond T cell exhaustion: TIM-3 regulation of myeloid cells
Dixon, K. O., Lahore, G. F., & Kuchroo, V. K. (2024) · Science Immunology · doi:10.1126/sciimmunol.adf2223 · Cited by 93
“Some reports also point to an association between TIM-3 and T cell exhaustion/dysfunction in the context of autoimmune inflammation ( 50 , 103 ).”
BackgroundMethodInfluentialSelf-citationYin, N., Li, X., Zhang, X., Xue, S., Cao, Y., Niedermann, G., Lu, Y., & Xue, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01826-z · Cited by 79
Ma, S., Tian, Y., Peng, J., Chen, C., Peng, X., Zhao, F., Li, Z., Li, M., Zhao, F., Sheng, X., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg6752 · Cited by 68
Tim-3 adapter protein Bat3 acts as an endogenous regulator of tolerogenic dendritic cell function
Tang, R., Acharya, N., Subramanian, A., Purohit, V., Tabaka, M., Hou, Y., He, D., Dixon, K. O., Lambden, C., Xia, J., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abm0631 · Cited by 59
“RESULTS The absence of Bat3 expression in DCs alters the cross-talk between DCs and T cells To study the cell-intrinsic function of Bat3 in regulating DC functions, we used Bat3fl/flCD11cCRE [hereby referred to as Bat3 conditional knockout (cKO)] mice (21).”
MethodSelf-citationPD-1 and TIM-3 differentially regulate subsets of mouse IL-17A–producing γδ T cells
Edwards, S. C., Hedley, A., Hoevenaar, W. H. M., Wiesheu, R., Glauner, T. A., Kilbey, A., Shaw, R., Boufea, K., Batada, N. N., Hatano, S., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211431 · Cited by 60
“We also investigated phosphorylation of FOXO1 by Western blot, since this transcription factor inhibits RORγt (Lainé et al., 2015) and functions downstream of TCR and PD1 signaling in αβ T cells (Staron et al., 2014).”
InfluentialRecent progress in immune evasion mechanisms of triple-negative breast cancer
Yang, Y., & Wang, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07370-w · Cited by 63
Wang, J., Wang, Y., Jiang, X., Xu, M., Wang, M., Wang, R., Zheng, B., Chen, M., Qi, K., & Long, J. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216758 · Cited by 44
Rahimi, A. R., Baghernejadan, Z., Hazrati, A., Malekpour, K., Samimi, L. N., Najafi, A., Falak, R., & Khorramdelazad, H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118014 · Cited by 44
Zhu, Q., Yang, Y., Chen, K., Zhang, Q., Huang, Y., & Jian, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05002-3 · Cited by 32
“These TFs are closely associated with TIM3 expression [39, 40] and CD8 + TILs exhaustion [41, 42], among which STAT1 was identified as the critical TF that regulated the expression of TIM3 in CD8 + TILs from DLBCL.”
BackgroundRoussot, N., Kaderbhaï, C., & Ghiringhelli, F. (2025) · Cancers · doi:10.3390/cancers17050906 · Cited by 34
“Regarding exhaustion, TIM-3 T cells are considered as terminally differentiated exhausted T cells [185].”
Metabolic regulation and function of T helper cells in neuroinflammation
Spiljar, M., & Kuchroo, V. K. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00959-z · Cited by 31
Self-citationChen, H., Zha, J., Tang, R., & Chen, G. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110418 · Cited by 31
Zhou, H., Jia, W., Lu, L., & Han, R. (2023) · Cancers · doi:10.3390/cancers15030824 · Cited by 22
“TIM-3 Galactin-9, CEACAM1, HMGB1, PS Tumorinfiltrating T cells, Tregs, DCs, monocytes, NK cells Exhausting tumorinfiltrated T cells Glycosylated TIM3/AKT/mTOR signaling; phosphorylated TIM3/NFAT/Bat signaling Sabatolimab (phase III); MAS825 (phase III) RAPA-201 (phase I/II) NA [47,48]”
BackgroundZhang, F., Li, M., Zhou, H., Zhong, X., Zhang, Z., Meng, X., Jiang, Y., Wang, T., & Li, N. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1674163 · Cited by 21
Czaja, A. J. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-07967-5 · Cited by 19
“The lysosome-associated membrane protein-2 isoform (LAMP2a) promotes the presentation of peptides by MHC class II molecules [267, 268], and the human leukocyte antigen (HLA)-B-associated transcript 3 (Bat3) protects autoreactive T cell responses by preventing T cell exhaustion [269, 270].”
BackgroundAn Emerging Role of TIM3 Expression on T Cells in Chronic Kidney Inflammation
Lu, C., Chen, H., Wang, C., Yang, F., Li, J., Liu, H., & Chen, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.798683 · Cited by 14
“Upon binding of ligands, the release of BAT3 from phosphorylated Tyr256 and Tyr263 can activate TIM3 signaling by mechanistically inhibiting the mTORC2-AKT pathway in T cells (62).”
BackgroundSelf-citationThe role of TIM-3 in sepsis: a promising target for immunotherapy?
Wang, C., Liu, J., Wu, Q., Wang, Z., Hu, B., & Bo, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1328667 · Cited by 16
Self-citationThe Role of TIM-3 in Glioblastoma Progression
Ahmady, F., Sharma, A., Achuthan, A. A., Kannourakis, G., & Luwor, R. B. (2025) · Cells · doi:10.3390/cells14050346 · Cited by 16
“…1 (BLIMP1) that mediates the regulation of several genes involved in T cell dysfunction and apoptosis [60,62,63]. transcriptional activity of B-lymphocyte-induced maturation protein 1 (BLIMP1) that mediates the regulation of several genes involved in T cell dysfunction and apoptosis [60,62,63].”
Involvement of Tim-3 in Maternal-fetal Tolerance: A Review of Current Understanding
Meng, X., Luo, Y., Cui, L., & Wang, S. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.106115 · Cited by 11
“Tim-3 marked terminally differentiated and dysfunctional T cells in experimental autoimmune encephalomyelitis (EAE)[80].”
Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation
Ahmady, F., Curpen, P., Perriman, L., Teixeira, A. F., Wu, S., Zhu, H., Poddar, A., Jayachandran, A., Kannourakis, G., & Luwor, R. B. (2024) · Cells · doi:10.3390/cells13211777 · Cited by 10
Innovative gene engineering and drug delivery systems for dendritic cells in cancer immunotherapy
Prakash, M., Cortez, C. D., Jayaraman, A., Hsu, S.-Y., Huang, Y., Yeh, C.-Y., & Lee, Y. L. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01191-1 · Cited by 10
“Notably, the absence of the adaptor protein BAT3 in DCs enhances a tolerogenic phenotype and induces a hyperactive unfolded protein response (UPR), promoting T cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) dominance and impairing antitumor T cell activity [83].”
Akbar, I., Tang, R., Baillargeon, J., Roy, A.-P., Doss, P. M. I. A., Zhu, C. Y., Kuchroo, V. K., & Rangachari, M. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300526 · Cited by 9
Self-citationAbadi, R. N. S., Abadi, Z., & Hooshmand, S. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11367-5 · Cited by 9
“This cytoplasmic molecule prevents premature activation of TIM-3 signaling and cellular death from Gal-9, with its expression being increased during T-cell expansion and differentiation resulting in increased TIM-3 signaling [52].”
Czaja, A. J. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08118-6 · Cited by 6
“They can influence dendritic cell function [58], facilitate antigen cross-presentation [59–65], and promote an autoreactive T cell response [66, 67].”
BackgroundInfluentialMeyaard, L., & van der Vlist, M. (2026) · Annual Review of Immunology · doi:10.1146/annurev-immunol-083024-025659 · Cited by 3
Tim-3 agonist restrains ILC2 function and attenuates airway hyperreactivity via NLK pathway
Sakano, Y., Sakano, K., Kokubo, K., Hurrell, B. P., Shen, S. M.-C., Li, X., Swamy, G. Y. S., Cain, J., Kuchroo, V. K., & Akbari, O. (2026) · Nature Communications · doi:10.1038/s41467-026-71336-9 · Cited by 2
“For Tim-3 agonist studies, anti-Tim-3 monoclonal antibody (clone 5D12, Cell Essentials) (Tim-3 agonist) 22 or isotypecontrol(mouseIgG1,cloneP3.”
Self-citationT cell exhaustion: next-generation target of autoimmune diseases?
Ouyang, Y., Luo, M., Li, K., Chen, K., Wen, Z., Zhou, Q., Shi, G., Xu, S., Luo, Z., & Yang, H. U. I. (2026) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiag052 · Cited by 1
TIM-3 in AML: a janus-faced orchestrator of immune exhaustion and leukemic self-renewal
Hjazi, A. M. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04337-9 · Cited by 1
“…to a transcriptional and functional program of exhaustion, but during normal immune responses it may also be transiently upregulated on recently activated effector T cells, where it acts as a physiological brake that limits excessive activation and helps shape contraction/homeostasis [34, 35].”
The Biology of Immune Checkpoint Blockade
Bullock, T. N. J. (2024) · Wiley eBooks · doi:10.1002/9781119824572.ch10
The molecules with double-edged sword roles in T cell: An implication for adoptive T cell therapy
Samiee, M., Salehi, S., Khosroshahi, L. M., & Soltantoyeh, T. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104810
Zhu, Q., Yang, Y., Chen, K., Zhang, Q., Huang, Y., & Jian, S. (2024) · Figshare · doi:10.6084/m9.figshare.26682370
Zhu, Q., Yang, Y., Chen, K., Zhang, Q., Huang, Y., & Jian, S. (2024) · Figshare · doi:10.6084/m9.figshare.26682367
Dolui, B., Majumdar, B., Bandyopadhyay, A., Desai, K. V., & BASU, A. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111096 · Cited by 1
“Previous studies reported that PI3K-Akt kinase activity is enhanced by Bat3 deficiency without affecting other down-stream mediators of TCR activation (22).”
Zhao, Y., Tang, Z., Tao, Y., Zhao, S., Ding, Q., & Yang, W. (2026) · Scientific Reports · doi:10.1038/s41598-026-45579-x
“In T cells, it promotes metabolic programs required for activation and clonal expansion 44,45 .”
Inhibitory receptor agonists: Emerging strategies in immune modulation
Adam, K. R., Suhail, A., Kuchroo, V. K., & Vignali, D. A. A. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20241217 · Cited by 1
Self-citationNISHIUE, F. (2022) · Institutional Repositories DataBase (IRDB)
Metadata
- Authors
- Zhu, C., Dixon, K. O., Newcomer, K., Gu, G., Xiao, S., Zaghouani, S., Schramm, M. A., Wang, C., Zhang, H., Goto, K., Christian, E., Rangachari, M., Rosenblatt-Rosen, O., Okada, H., Mak, T., Singer, M., Regev, A., & Kuchroo, V.
- Affiliations
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Harvard University (US)
- Celsius Therapeutics (United States) (US)
- University Health Network (CA)
- Department of Data Sciences, DFCI, Boston, MA 02215, USA.
- Université Laval (CA)
- Kindai University (JP)
- Corresponding author
- Zhu, Chen
- Dixon, Karen O.
- Kuchroo, Vijay
- ORCID
- Venue
- Science Advances
- Published
- 2021-04-30
- Volume
- 7
- Issue
- 18
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC8087420
- OpenAlex
- W3159845336
- Cited by
- 40
- References
- 53
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 9 · 2023: 9 · 2022: 5
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Funders
- Japan Society for the Promotion of Science (21K07135)
- National Institute of Allergy and Infectious Diseases (P01AI073748, U19AI133524, P01AI056299)
- National Institute of Neurological Disorders and Stroke (R01NS030843, R29NS030843, P01NS038037, R37NS030843, R01NS045937)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- BAT3, TIM-3, T cell exhaustion, T cell dysfunction, autoimmune disease, effector function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.